Review of Low-Cost 3D Bioprinters: State of the Market and Observed Future Trends.
2021
Three-dimensional (3D) bioprinting has become mainstream for precise and repeatable high-throughput fabrication of complex cell cultures and tissue constructs in drug testing and regenerative medic...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
191
References
1
Citations
NaN
KQI